Israel
Intelligence de marché des dispositifs médicaux pour Israel. Changements réglementaires, concurrents et tendances d'achats.
Signaux des 7 derniers jours
RenalSense secured $14 million for Clarity RMS expansion in critical care monitoring across global markets.
PatenSee has begun a first-in-human trial for its contactless imaging system for haemodialysis patients' fistula stenosis.
PatenSee's contactless imaging device shows promise for timely monitoring of vascular access stenosis in dialysis patients.
The REDUCED-1 study for the TIVUS renal denervation system has completed patient enrollment for hypertension treatment.